Who Paid My Doc
New InsiGHts
ClinicalTrials.gov NCT05690386
Research payments
$2,101,907
Through program year 2025, $2,101,907 in research payments was reported against New InsiGHts, across 967 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- NCT05690386
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $446,356 | 264 |
| 2024 | Research | $1,064,683 | 666 |
| 2023 | Research | $590,868 | 37 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Doris Fadoju Atlanta, GA Named on 128 payments
- Shanlee Davis Aurora, CO Named on 122 payments
- Mauri Carakushansky Rockland, DE Named on 85 payments
- Reema Habiby Chicago, IL Named on 75 payments
- Jennifer Law Chapel Hill, NC Named on 54 payments
- Karen Klein San Diego, CA Named on 51 payments
- Patricia Fechner Seattle, WA Named on 47 payments
- Hector Granados El Paso, TX Named on 44 payments
- Kathryn Woods Portland, OR Named on 36 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.